Haemolytic disease of the fetus and newborn due to anti-Fya and the potential clinical value of Duffy genotyping in pregnancies at risk

Transfusion Medicine

Volumn 7, Issue 4, 1997, Pages 301-304

  Goodrick, M J ^a   Hadley, A G ^a   Poole, G ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Anti Fya; Duffy genotyping; HDN

Indexed keywords

EID: 0031435323     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1997.d01-38.x     Document Type: Article

References (8)

1. BCSH Blood Transfusion Task Force. (1996a) Guidelines for blood grouping and red cell antibody testing during pregnancy. Transfusion Medicine, 6, 71-74.
2. BCSH Blood Transfusion Task Force. (1996b) Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 6, 273-283.
3. a) haemolytic disease. Australian and New Zealand Journal of Obstetrics and Gynaecology, 29, 263-264.
4. Dufour, P., Vinatier, D., Bernardi, C., Ezzedine, M., Fonteyne, G., Monnier, J.C. & Mannessier, L. (1991) Allo-immunisation foeto-maternelle grave anti-Duffy. Journal de Gynecologie. Obstetrique et Biologie de la Reproduction (Paris), 20, 809-814.
5. Hadley, A.G., Kumpel, B.M., Leader, K.A., Poole, G.D. & Fraser, I.D. (1991) Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. British Journal of Haematology, 77, 221-228.
6. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy (a-b-) phenotype. British Journal of Haematology, 90, 823-829.
7. Mollison, P.L., Engelfriet, C.P. & Contreras, M. (1993) Blood Transfusion in Clinical Medicine, 9th edn. Blackwell Science, Oxford, 582.
8. a. American Journal of Obstetrics and Gynecology, 121, 643-645.